Craig A. Tooman is CFO & Exec VP Finance at ENZON PHARMACEUTICALS INC (ENZN). They have made 8 open-market trades across 2 companies since 2006, most recently 2019-07-18.
CIK 0001201050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $15K since 2006, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PETX | SELL | 2018-01-11 | 2018-01-12 | $5.27 | $158K | -8.0% | -21.7% | -2.3% |
| PETX | SELL | 2016-09-09 | 2016-09-12 | $9.25 | $278K | +2.8% | -0.7% | -13.2% |
| PETX | SELL · 10b5-1 | 2016-02-01 | 2016-02-02 | $3.36 | $9K | -16.7% | +22.2% | +89.8% |
| PETX | SELL · 10b5-1 | 2015-11-09 | 2015-11-10 | $7.52 | $27K | -45.1% | -7.4% | -45.5% |
| PETX | SELL · 10b5-1 | 2015-10-02 | 2015-10-02 | $8.06 | $26K | -45.1% | -7.4% | -7.4% |
| ENZN | SELL | 2010-06-18 | 2010-06-22 | $11.25 | $1.4M | -11.7% | -7.1% | -7.1% |
| ENZN | SELL | 2010-02-24 | 2010-02-26 | $9.27 | $1.4M | -11.7% | -7.1% | -7.1% |
| ENZN | SELL | 2009-04-03 | 2009-04-07 | $6.12 | $36K | -11.7% | -7.1% | -7.1% |
| ENZN | SELL | 2009-01-17 | 2009-01-21 | $6.33 | $65K | -11.7% | -7.1% | -7.1% |
| ENZN | BUY | 2007-05-11 | 2007-05-14 | $8.19 | $8K | -11.7% | -7.1% | -7.1% |
| ENZN | BUY | 2006-03-07 | 2006-03-07 | $6.87 | $7K | -11.7% | -7.1% | -7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.